Global Antacids Market Size study & Forecast, by Formulation Type (Tablet, Powder, Others) By Distribution Channel (Hospital Pharmacies, E-Commerce, Others) and Regional Analysis, 2023-2030
Global Antacids Market is valued approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Antacid is a sort of medicine that aids to reduce stomach acid and alleviates symptoms associated to excess acid. These over-the-counter medications have sodium bicarbonate, calcium, magnesium, or aluminum as active ingredients. They function by combining with stomach acid to create neutral chemicals that can lessen the acidity of the stomach contents. Antacids can therefore be used to treat symptoms including indigestion, heartburn, and acid reflux. Antacids are frequently used to treat symptoms brought on by excessive stomach acid. They aid in balancing the acid that is responsible for the burning in the chest or stomach. The key factor driving the market growth is rising prevalence of acid reflux and GERD, easy availability of OTC antacids, and rise in the demand for antacids among geriatric population that anticipated to support the market growth during forecast period.
Moreover, the rising geriatric population is one of the factors contributing to the growth of the antacids market. As people age, they are more prone to developing gastrointestinal problems such as acid reflux, heartburn, and gastroesophageal reflux disease (GERD). These conditions can cause discomfort and pain in the chest and throat and can also lead to other health complications. Thus, the rising geriatric population is anticipated to support the market growth. According to The World Bank, in 2015, the number of people aged 65 and above in India was 74.61 million and the number reached 95.75 million in 2021. Also, according to the same source, in 2016, the 22% of total population ages 65 and above in Italy and the number is reached 24% in 2021. As a result, the rising geriatric population in the region is anticipated to create a lucrative demand for the market. Additionally, rapidly changing lifestyle of global population is anticipated to create the lucrative opportunity for the market during forecast period. However, the growing number of alternatives in the market for antacids may stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Antacids Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, availability of well-developed healthcare infrastructure, increase in incidences of heart burn cases, and easy availability of over-the-counter medication in this region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing presence of pharmaceutical companies, increase in healthcare expenditure and rise in awareness among people about heart burn are expected to drive market growth.
Major market player included in this report are:
Abbott Laboratories
Alkem Laboratories Ltd.
Bayer AG
Cipla Ltd
Haleon plc
Infirst Healthcare Inc.
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Reckitt Benckiser Group PLC,
WellSpring Pharmaceutical Corporation
Recent Developments in the Market:
In June 2022, Zydus Lifesciences received final approval from the United States Food and Drug Administration (FDA) to market Famotidine tablets in the strengths of 20 mg and 40 mg. Famotidine is a histamine H2 receptor blocker. It works by reducing the amount of acid in the stomach.
Global Antacids Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Formulation Type, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Formulation Type:
Tablet
Powder
Others
By Distribution Channel:
Hospital Pharmacies
E-Commerce
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Moreover, the rising geriatric population is one of the factors contributing to the growth of the antacids market. As people age, they are more prone to developing gastrointestinal problems such as acid reflux, heartburn, and gastroesophageal reflux disease (GERD). These conditions can cause discomfort and pain in the chest and throat and can also lead to other health complications. Thus, the rising geriatric population is anticipated to support the market growth. According to The World Bank, in 2015, the number of people aged 65 and above in India was 74.61 million and the number reached 95.75 million in 2021. Also, according to the same source, in 2016, the 22% of total population ages 65 and above in Italy and the number is reached 24% in 2021. As a result, the rising geriatric population in the region is anticipated to create a lucrative demand for the market. Additionally, rapidly changing lifestyle of global population is anticipated to create the lucrative opportunity for the market during forecast period. However, the growing number of alternatives in the market for antacids may stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Antacids Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, availability of well-developed healthcare infrastructure, increase in incidences of heart burn cases, and easy availability of over-the-counter medication in this region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing presence of pharmaceutical companies, increase in healthcare expenditure and rise in awareness among people about heart burn are expected to drive market growth.
Major market player included in this report are:
Abbott Laboratories
Alkem Laboratories Ltd.
Bayer AG
Cipla Ltd
Haleon plc
Infirst Healthcare Inc.
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Reckitt Benckiser Group PLC,
WellSpring Pharmaceutical Corporation
Recent Developments in the Market:
In June 2022, Zydus Lifesciences received final approval from the United States Food and Drug Administration (FDA) to market Famotidine tablets in the strengths of 20 mg and 40 mg. Famotidine is a histamine H2 receptor blocker. It works by reducing the amount of acid in the stomach.
Global Antacids Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Formulation Type, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Formulation Type:
Tablet
Powder
Others
By Distribution Channel:
Hospital Pharmacies
E-Commerce
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Antacids Market, by Region, 2020-2030 (USD Billion)
1.2.2. Antacids Market, by Formulation Type, 2020-2030 (USD Billion)
1.2.3. Antacids Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ANTACIDS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ANTACIDS MARKET DYNAMICS
3.1. Antacids Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of acid reflux and GERD
3.1.1.2. Easy availability of OTC antacids
3.1.1.3. Rise in the demand for antacids among geriatric population
3.1.2. Market Challenges
3.1.2.1. Availability of substitute
3.1.3. Market Opportunities
3.1.3.1. Rapidly changing lifestyle of global population
CHAPTER 4. GLOBAL ANTACIDS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ANTACIDS MARKET, BY FORMULATION TYPE
5.1. Market Snapshot
5.2. Global Antacids Market by Formulation Type, Performance - Potential Analysis
5.3. Global Antacids Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
5.4. Antacids Market, Sub Segment Analysis
5.4.1. Tablet
5.4.2. Powder
5.4.3. Others
CHAPTER 6. GLOBAL ANTACIDS MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Antacids Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Antacids Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Antacids Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. E-Commerce
6.4.3. Others
CHAPTER 7. GLOBAL ANTACIDS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Antacids Market, Regional Market Snapshot
7.4. North America Antacids Market
7.4.1. U.S. Antacids Market
7.4.1.1. Formulation Type breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Antacids Market
7.5. Europe Antacids Market Snapshot
7.5.1. U.K. Antacids Market
7.5.2. Germany Antacids Market
7.5.3. France Antacids Market
7.5.4. Spain Antacids Market
7.5.5. Italy Antacids Market
7.5.6. Rest of Europe Antacids Market
7.6. Asia-Pacific Antacids Market Snapshot
7.6.1. China Antacids Market
7.6.2. India Antacids Market
7.6.3. Japan Antacids Market
7.6.4. Australia Antacids Market
7.6.5. South Korea Antacids Market
7.6.6. Rest of Asia Pacific Antacids Market
7.7. Latin America Antacids Market Snapshot
7.7.1. Brazil Antacids Market
7.7.2. Mexico Antacids Market
7.8. Middle East & Africa Antacids Market
7.8.1. Saudi Arabia Antacids Market
7.8.2. South Africa Antacids Market
7.8.3. Rest of Middle East & Africa Antacids Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Alkem Laboratories Ltd.
8.3.3. Bayer AG
8.3.4. Cipla Ltd
8.3.5. Haleon plc
8.3.6. Infirst Healthcare Inc.
8.3.7. Pfizer Inc.
8.3.8. Prestige Consumer Healthcare Inc.
8.3.9. Reckitt Benckiser Group PLC,
8.3.10. WellSpring Pharmaceutical Corporation
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Antacids Market, by Region, 2020-2030 (USD Billion)
1.2.2. Antacids Market, by Formulation Type, 2020-2030 (USD Billion)
1.2.3. Antacids Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL ANTACIDS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL ANTACIDS MARKET DYNAMICS
3.1. Antacids Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of acid reflux and GERD
3.1.1.2. Easy availability of OTC antacids
3.1.1.3. Rise in the demand for antacids among geriatric population
3.1.2. Market Challenges
3.1.2.1. Availability of substitute
3.1.3. Market Opportunities
3.1.3.1. Rapidly changing lifestyle of global population
CHAPTER 4. GLOBAL ANTACIDS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL ANTACIDS MARKET, BY FORMULATION TYPE
5.1. Market Snapshot
5.2. Global Antacids Market by Formulation Type, Performance - Potential Analysis
5.3. Global Antacids Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
5.4. Antacids Market, Sub Segment Analysis
5.4.1. Tablet
5.4.2. Powder
5.4.3. Others
CHAPTER 6. GLOBAL ANTACIDS MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Snapshot
6.2. Global Antacids Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Antacids Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
6.4. Antacids Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. E-Commerce
6.4.3. Others
CHAPTER 7. GLOBAL ANTACIDS MARKET, REGIONAL ANALYSIS
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Antacids Market, Regional Market Snapshot
7.4. North America Antacids Market
7.4.1. U.S. Antacids Market
7.4.1.1. Formulation Type breakdown estimates & forecasts, 2020-2030
7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Antacids Market
7.5. Europe Antacids Market Snapshot
7.5.1. U.K. Antacids Market
7.5.2. Germany Antacids Market
7.5.3. France Antacids Market
7.5.4. Spain Antacids Market
7.5.5. Italy Antacids Market
7.5.6. Rest of Europe Antacids Market
7.6. Asia-Pacific Antacids Market Snapshot
7.6.1. China Antacids Market
7.6.2. India Antacids Market
7.6.3. Japan Antacids Market
7.6.4. Australia Antacids Market
7.6.5. South Korea Antacids Market
7.6.6. Rest of Asia Pacific Antacids Market
7.7. Latin America Antacids Market Snapshot
7.7.1. Brazil Antacids Market
7.7.2. Mexico Antacids Market
7.8. Middle East & Africa Antacids Market
7.8.1. Saudi Arabia Antacids Market
7.8.2. South Africa Antacids Market
7.8.3. Rest of Middle East & Africa Antacids Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Alkem Laboratories Ltd.
8.3.3. Bayer AG
8.3.4. Cipla Ltd
8.3.5. Haleon plc
8.3.6. Infirst Healthcare Inc.
8.3.7. Pfizer Inc.
8.3.8. Prestige Consumer Healthcare Inc.
8.3.9. Reckitt Benckiser Group PLC,
8.3.10. WellSpring Pharmaceutical Corporation
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Antacids Market, report scope
TABLE 2. Global Antacids Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Antacids Market estimates & forecasts by Formulation Type 2020-2030 (USD Billion)
TABLE 4. Global Antacids Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Antacids Market
TABLE 70. List of primary sources, used in the study of global Antacids Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Antacids Market, report scope
TABLE 2. Global Antacids Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Antacids Market estimates & forecasts by Formulation Type 2020-2030 (USD Billion)
TABLE 4. Global Antacids Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 5. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Antacids Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Antacids Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Antacids Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Antacids Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Antacids Market
TABLE 70. List of primary sources, used in the study of global Antacids Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Antacids Market, research methodology
FIG 2. Global Antacids Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Antacids Market, key trends 2022
FIG 5. Global Antacids Market, growth prospects 2023-2030
FIG 6. Global Antacids Market, porters 5 force model
FIG 7. Global Antacids Market, pest analysis
FIG 8. Global Antacids Market, value chain analysis
FIG 9. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Antacids Market, regional snapshot 2020 & 2030
FIG 15. North America Antacids Market 2020 & 2030 (USD Billion)
FIG 16. Europe Antacids Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Antacids Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Antacids Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Antacids Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Antacids Market, research methodology
FIG 2. Global Antacids Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Antacids Market, key trends 2022
FIG 5. Global Antacids Market, growth prospects 2023-2030
FIG 6. Global Antacids Market, porters 5 force model
FIG 7. Global Antacids Market, pest analysis
FIG 8. Global Antacids Market, value chain analysis
FIG 9. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Antacids Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Antacids Market, regional snapshot 2020 & 2030
FIG 15. North America Antacids Market 2020 & 2030 (USD Billion)
FIG 16. Europe Antacids Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Antacids Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Antacids Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Antacids Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
